SCHEMBL4711642

SCHEMBL4711642

CCc1ccsc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7164477 0.77
SCHEMBL27644928 0.76 TYR (0.41)
SCHEMBL11121532 0.75
SCHEMBL11081057 0.75
SCHEMBL2981174 0.75
SCHEMBL21962268 0.75
SCHEMBL22521369 0.75 SLC6A2 (0.33)
SCHEMBL20733705 0.75
SCHEMBL2990023 0.75 SLC6A4 (0.38)
SCHEMBL9631536 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431323-A Heterobicyclic amides as CD38 inhibitors 贝林格尔·英格海姆国际有限公司 2025-02-14 CN disclosed
CN-114423753-B Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2024-09-17 CN disclosed
CN-102365277-B JUN N-terminal kinase inhibitors ELAN PHARMACEUTICALS, INC. (US) 2015-11-25 CN disclosed
US-8119645-B2 Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE AG (DE) 2012-02-21 US disclosed
EP-2019825-B9 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INT (DE) 2011-01-26 EP disclosed
EP-2019825-B1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INT (DE) 2010-09-01 EP disclosed
US-20100197657-A1 2-ARYL OR HETEROARYL INDOLE DERIVATIVES CHANG RONALD K 2010-08-05 US disclosed
US-20090291969-A1 Fungicide hydroximoyl-tetrazole derivatives BAYER CROPSCIENCE AG (DE) 2009-11-26 US disclosed
EP-2007772-A1 THIAZOLYL-DIHYDROQUINAZOLINES Boehringer Ingelheim International GmbH (DE) 2008-12-31 EP disclosed
WO-2007131350-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-11-22 WO disclosed
EP-0142027-A1 5-Substituted-delta-2-imidazolinyl-thio ethers, and process for their production HOECHST AKTIENGESELLSCHAFT (DE) 1985-05-22 EP disclosed
EP-0008077-B1 PROSTAGLANDIN DERIVATIVES WITH A DELTA-2-PGF2 STRUCTURE OR A DELTA-2-PGE2 STRUCTURE, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS HOECHST AKTIENGESELLSCHAFT (DE) 1983-11-16 EP disclosed
EP-0065200-A2 Thiolactime ethers of delta-1-pyrrolidine, and their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1982-11-24 EP disclosed
EP-0055851-A1 11-Deoxy-hetero-imino-prostacyclins, processes for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1982-07-14 EP disclosed
US-4312882-A ANTICOAGULANTS, HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1982-01-26 US disclosed
US-4304783-A ANTITHROMBOTIC, ANTIINFARCT, HYPOTENSIVE AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-08 US disclosed
US-4296121-A HYPOTENSIVE AGENTS, ANTICOAGULANTS HOECHST AKTIENGESELLSCHAFT (DE) 1981-10-20 US disclosed
EP-0029527-A2 Prostaglandin derivatives of the 6-keto-PGA1 series, process for their production as well as their use in medicaments and their intermediate products HOECHST AKTIENGESELLSCHAFT (DE) 1981-06-03 EP disclosed
EP-0013955-A1 Analogues of prostacyclin, their intermediates, a process for their preparation and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1980-08-06 EP disclosed
EP-0008077-A2 Prostaglandin derivatives with a delta-2-PGF2 structure or a delta-2-PGE2 structure, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1980-02-20 EP disclosed